Staunch biotech competition spurs new secretive tactics, shifts investor approach - Pharmaceutical Technology

Biotechs and investors are increasingly altering their strategies amid changes in the development and commercial landscape. Biotechs and investors are increasingly altering their strategies amid changes in the development and commercial landscape. Biotechs say they are being increasingly secretive amid several shifts in the development and commercial landscape. Credit: TukuYoTuku / Shutterstock.com. Unlock FREE Access to Premium Content ​Discover exclusive forecasts, analyst insights, and in-depth pharmaceutical industry analysis spanning drug development, manufacturing, regulation, and global healthcare trends. With a free Pharmaceutical Technology profile, you can: The leading site for news and procurement in the pharmaceutical industry

Source: Pharmaceutical Technology